This case report highlights the severe risk of fatal ventricular fibrillation following intravenous administration of procaine amide.
May warrant caution with IV procainamide; single case leaves open broader safety assessment.
This is a report of death immediately following an intravenous injection of procaine amide ("pronestyl") hydrochloride. The case is reported because it is felt that instances of important untoward as well as the favorable effects of a drug should be generally known. Except for deaths in moribund patients and/or following exceedingly large, rapidly administered doses1no instances of death following the routine, cautious use of procaine amide have come to my attention. Aside from an increasingly cautious tone in the more recent articles2and an isolated report of agranulocytosis following oral administration,3most authors have mentioned the relative lack of serious toxic effects.4 REPORT OF A CASE A 61-year-old widow was admitted to the Elko General Hospital in June, 1951, after a third attack of acute weakness and dyspnea in 48 hours. She had had rheumatic fever at 11 years. In 1935 she was admitted to
No takes yet. Share an insight, caveat, or question.
J M Read (1952) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: